Afatinib Mediates Autophagic Degradation of ORAI1, STIM1, and SERCA2, Which Inhibits Proliferation of Non–Small Cell Lung Cancer Cells

Background The expression of calcium signaling pathway molecules is altered in various carcinomas, which are related to the proliferation and altered characteristics of cancer cells. However, changes in calcium signaling in anti-cancer drug-resistant cells (bearing a T790M mutation in epidermal grow...

Full description

Bibliographic Details
Main Authors: Mi Seong Kim, So Hui Kim, Sei-Hoon Yang, Min Seuk Kim
Format: Article
Language:English
Published: The Korean Academy of Tuberculosis and Respiratory Diseases 2022-04-01
Series:Tuberculosis and Respiratory Diseases
Subjects:
Online Access:http://www.e-trd.org/upload/pdf/trd-2021-0095.pdf
_version_ 1819010519909007360
author Mi Seong Kim
So Hui Kim
Sei-Hoon Yang
Min Seuk Kim
author_facet Mi Seong Kim
So Hui Kim
Sei-Hoon Yang
Min Seuk Kim
author_sort Mi Seong Kim
collection DOAJ
description Background The expression of calcium signaling pathway molecules is altered in various carcinomas, which are related to the proliferation and altered characteristics of cancer cells. However, changes in calcium signaling in anti-cancer drug-resistant cells (bearing a T790M mutation in epidermal growth factor receptor [EGFR]) remain unclear. Methods Afatinib-mediated changes in the level of store-operated Ca2+ entry (SOCE)-related proteins and intracellular Ca2+ level in non–small cell lung cancer cells with T790M mutation in the EGFR gene were analyzed using western blot and ratiometric assays, respectively. Afatinib-mediated autophagic flux was evaluated by measuring the cleavage of LC3B-II. Flow cytometry and cell proliferation assays were conducted to assess cell apoptosis and proliferation. Results The levels of SOCE-mediating proteins (ORAI calcium release-activated calcium modulator 1 [ORAI1], stromal interaction molecule 1 [STIM1], and sarco/endoplasmic reticulum Ca2+ ATPase [SERCA2]) decreased after afatinib treatment in non–small cell lung cancer cells, whereas the levels of SOCE-related proteins did not change in gefitinibresistant non–small cell lung cancer cells (PC-9/GR; bearing a T790M mutation in EGFR). Notably, the expression level of SOCE-related proteins in PC-9/GR cells was reduced also responding to afatinib in the absence of extracellular Ca2+. Moreover, extracellular Ca2+ influx through the SOCE was significantly reduced in PC-9 cells pre-treated with afatinib than in the control group. Additionally, afatinib was found to decrease the level of SOCE-related proteins through autophagic degradation, and the proliferation of PC-9GR cells was significantly inhibited by a lack of extracellular Ca2+. Conclusion Extracellular Ca2+ plays important role in afatinib-mediated autophagic degradation of SOCE-related proteins in cells with T790M mutation in the EGFR gene and extracellular Ca2+ is essential for determining anti-cancer drug efficacy.
first_indexed 2024-12-21T01:13:34Z
format Article
id doaj.art-86650daf4fee4f0f9f475bd3188dbf6b
institution Directory Open Access Journal
issn 1738-3536
2005-6184
language English
last_indexed 2024-12-21T01:13:34Z
publishDate 2022-04-01
publisher The Korean Academy of Tuberculosis and Respiratory Diseases
record_format Article
series Tuberculosis and Respiratory Diseases
spelling doaj.art-86650daf4fee4f0f9f475bd3188dbf6b2022-12-21T19:20:51ZengThe Korean Academy of Tuberculosis and Respiratory DiseasesTuberculosis and Respiratory Diseases1738-35362005-61842022-04-0185214715410.4046/trd.2021.00954604Afatinib Mediates Autophagic Degradation of ORAI1, STIM1, and SERCA2, Which Inhibits Proliferation of Non–Small Cell Lung Cancer CellsMi Seong Kim0So Hui Kim1Sei-Hoon Yang2Min Seuk Kim3 Department of Oral Physiology, Institute of Biomaterial-Implant, School of Dentistry, Wonkwang University, Iksan, Republic of Korea Department of Carbon Convergence Engineering, College of Engineering, Wonkwang University, Iksan, Republic of Korea Department of Internal Medicine, School of Medicine, Wonkwang University, Iksan, Republic of Korea Department of Oral Physiology, Institute of Biomaterial-Implant, School of Dentistry, Wonkwang University, Iksan, Republic of KoreaBackground The expression of calcium signaling pathway molecules is altered in various carcinomas, which are related to the proliferation and altered characteristics of cancer cells. However, changes in calcium signaling in anti-cancer drug-resistant cells (bearing a T790M mutation in epidermal growth factor receptor [EGFR]) remain unclear. Methods Afatinib-mediated changes in the level of store-operated Ca2+ entry (SOCE)-related proteins and intracellular Ca2+ level in non–small cell lung cancer cells with T790M mutation in the EGFR gene were analyzed using western blot and ratiometric assays, respectively. Afatinib-mediated autophagic flux was evaluated by measuring the cleavage of LC3B-II. Flow cytometry and cell proliferation assays were conducted to assess cell apoptosis and proliferation. Results The levels of SOCE-mediating proteins (ORAI calcium release-activated calcium modulator 1 [ORAI1], stromal interaction molecule 1 [STIM1], and sarco/endoplasmic reticulum Ca2+ ATPase [SERCA2]) decreased after afatinib treatment in non–small cell lung cancer cells, whereas the levels of SOCE-related proteins did not change in gefitinibresistant non–small cell lung cancer cells (PC-9/GR; bearing a T790M mutation in EGFR). Notably, the expression level of SOCE-related proteins in PC-9/GR cells was reduced also responding to afatinib in the absence of extracellular Ca2+. Moreover, extracellular Ca2+ influx through the SOCE was significantly reduced in PC-9 cells pre-treated with afatinib than in the control group. Additionally, afatinib was found to decrease the level of SOCE-related proteins through autophagic degradation, and the proliferation of PC-9GR cells was significantly inhibited by a lack of extracellular Ca2+. Conclusion Extracellular Ca2+ plays important role in afatinib-mediated autophagic degradation of SOCE-related proteins in cells with T790M mutation in the EGFR gene and extracellular Ca2+ is essential for determining anti-cancer drug efficacy.http://www.e-trd.org/upload/pdf/trd-2021-0095.pdfafatinibcalcium channelsnon–small cell lungautophagy
spellingShingle Mi Seong Kim
So Hui Kim
Sei-Hoon Yang
Min Seuk Kim
Afatinib Mediates Autophagic Degradation of ORAI1, STIM1, and SERCA2, Which Inhibits Proliferation of Non–Small Cell Lung Cancer Cells
Tuberculosis and Respiratory Diseases
afatinib
calcium channels
non–small cell lung
autophagy
title Afatinib Mediates Autophagic Degradation of ORAI1, STIM1, and SERCA2, Which Inhibits Proliferation of Non–Small Cell Lung Cancer Cells
title_full Afatinib Mediates Autophagic Degradation of ORAI1, STIM1, and SERCA2, Which Inhibits Proliferation of Non–Small Cell Lung Cancer Cells
title_fullStr Afatinib Mediates Autophagic Degradation of ORAI1, STIM1, and SERCA2, Which Inhibits Proliferation of Non–Small Cell Lung Cancer Cells
title_full_unstemmed Afatinib Mediates Autophagic Degradation of ORAI1, STIM1, and SERCA2, Which Inhibits Proliferation of Non–Small Cell Lung Cancer Cells
title_short Afatinib Mediates Autophagic Degradation of ORAI1, STIM1, and SERCA2, Which Inhibits Proliferation of Non–Small Cell Lung Cancer Cells
title_sort afatinib mediates autophagic degradation of orai1 stim1 and serca2 which inhibits proliferation of non small cell lung cancer cells
topic afatinib
calcium channels
non–small cell lung
autophagy
url http://www.e-trd.org/upload/pdf/trd-2021-0095.pdf
work_keys_str_mv AT miseongkim afatinibmediatesautophagicdegradationoforai1stim1andserca2whichinhibitsproliferationofnonsmallcelllungcancercells
AT sohuikim afatinibmediatesautophagicdegradationoforai1stim1andserca2whichinhibitsproliferationofnonsmallcelllungcancercells
AT seihoonyang afatinibmediatesautophagicdegradationoforai1stim1andserca2whichinhibitsproliferationofnonsmallcelllungcancercells
AT minseukkim afatinibmediatesautophagicdegradationoforai1stim1andserca2whichinhibitsproliferationofnonsmallcelllungcancercells